- Home
- TXO vs HQL Comparison
TXO vs HQL Comparison
Compare TXO & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | TXO | HQL |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Investment Managers |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 619.1M | 510.2M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | TXO | HQL |
|---|---|---|
| Price | $10.67 | $16.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.50 | N/A |
| AVG Volume (30 Days) | ★ 364.8K | 120.9K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | ★ 22.52% | 11.56% |
| EPS Growth | N/A | N/A |
| EPS | 0.36 | ★ 0.79 |
| Revenue | ★ $364,412,000.00 | N/A |
| Revenue This Year | $32.78 | N/A |
| Revenue Next Year | $10.18 | N/A |
| P/E Ratio | $29.75 | ★ $17.08 |
| Revenue Growth | ★ 27.66 | N/A |
| 52 Week Low | $10.63 | $11.34 |
| 52 Week High | $20.70 | $14.37 |
Technical Indicators
Market Signals| Indicator | TXO | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 18.00 | 49.17 |
| Support Level | $10.63 | $16.55 |
| Resistance Level | $12.65 | $17.25 |
| Average True Range (ATR) | 0.37 | 0.30 |
| MACD | -0.13 | -0.08 |
| Stochastic Oscillator | 8.14 | 45.45 |
Price Performance
Historical Comparison TXO
HQL
About TXO TXO Partners L.P.
TXO Partners LP is focused on the acquisition, development, optimization, and exploitation of oil, natural gas, and natural gas liquid reserves in North America.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.